Indeed, we see that in naive human BCC explants, tumors containing nuclear MRTF respond significantly to AP-1 inhibition with a decrease in Gli1 expression, while tumors with only cytoplasmic MRTF are less responsive. Here, JUN is linked to skin basal cell carcinoma.